Skip to main content

Table 2 Baseline characteristics of the study population

From: Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance

Parameter

FD global cohort (n = 63)

FD LVH negative (n = 25)

FD LVH positive (n = 38)

Healthy volunteers (n = 63)

Age (years)

48 ± 15

39 ± 16

54 ± 11

47 ± 16

Sex (M/F)

29/34

6/19

23/15

29/34

BSA (m2)

1.8[1.7, 2]

1.7[1.6,1.8]

1.9[1.7, 2]

1.9[1.7, 2]

LVH (%)

38(60)

0

38(100)

0

ERT (%)

49(78)

14(56)

35(92)

0

Any LGE (%)

30(54)

4(17)

26(79)

0

LGE infero-lateral wall

29(51)

4(17)

25(76)

0

  1. Data are expressed as n(percentage) or mean ± standard deviation.
  2. BSA: body surface area; LVH: left ventricular hypertrophy; ERT: enzymatic replacing therapy; LGE: late gadolinium enhancement.